Circulating tumor cells (CTCs) after neoadjuvant chemotherapy for triple negative breast cancer (TNBC)

被引：0
|
作者：
Lucci, A.
Hall, C.
Hess, K.
Ravenberg, E.
Clayborn, A.
Mittendorf, E.
Rauch, G.
Candelaria, R.
Moulder, S.
Thompson, A.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS18-P3-01-01
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-01-01
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Prognostic implications of circulating tumor cells (CTCs) after neoadjuvant chemotherapy for triple negative breast cancer (TNBC)
    Hall, C.
    Hess, R.
    Ravenberg, L.
    Clayborn, A.
    Rauch, G. M.
    Candelaria, R.
    Mittendorf, E. A.
    Moulder, S. L.
    Thompson, A.
    Lucci, A.
    ANNALS OF ONCOLOGY, 2018, 29
  • [2] Circulating Tumor Cells After Neoadjuvant Chemotherapy in Stage I–III Triple-Negative Breast Cancer
    Carolyn Hall
    Mandar Karhade
    Barbara Laubacher
    Amber Anderson
    Henry Kuerer
    Sarah DeSynder
    Anthony Lucci
    Annals of Surgical Oncology, 2015, 22 : 552 - 558
  • [3] Circulating Tumor Cells After Neoadjuvant Chemotherapy in Stage I-III Triple-Negative Breast Cancer
    Hall, Carolyn
    Karhade, Mandar
    Laubacher, Barbara
    Anderson, Amber
    Kuerer, Henry
    DeSynder, Sarah
    Lucci, Anthony
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : S552 - S558
  • [4] The prognostic role of circulating tumor DNA after neoadjuvant chemotherapy in triple negative breast cancer with residual tumor
    Roseshter, Talia
    Klemantovich, Anna
    Cavallone, Luca
    Aguilar-Mahecha, Adriana
    Lafleur, Josiane
    Elebute, Oluwadara O.
    Jenna, Sarah
    Boileau, Jean-Francois
    Pelmus, Manuela
    Basik, Mark
    Lan, Cathy
    CANCER RESEARCH, 2023, 83 (05)
  • [5] Phenotypic characterization of circulating tumor cells (CTCs) in triple negative breast cancer patients
    Kallergi, Galatea
    Markomanoiaki, Haris
    Mavroudis, Dimitrios
    Georgoulias, Vassills
    Agelaki, Sofia
    CANCER RESEARCH, 2013, 73 (08)
  • [6] Phenotypic characterization of circulating tumor cells (CTCs) in triple negative breast cancer patients
    Kallergi, G.
    Agelaki, S.
    Mathioudaki, A.
    Mavroudis, D.
    Georgoulias, V.
    EJC SUPPLEMENTS, 2010, 8 (07): : 156 - 156
  • [7] Characteristics of residual tumor after neoadjuvant chemotherapy (nact) may predict outcomes in patients with triple negative breast cancer (tnbc)
    Frolova, M.
    Glazkova, E.
    Petrovsky, A.
    Rumyantsev, A.
    Stenina, M.
    Tjulandin, S.
    BREAST, 2023, 68 : S58 - S58
  • [8] Biomarker identification of residual triple negative breast cancer (TNBC) after standard neoadjuvant chemotherapy (NCT)
    Sohn, Joohyuk
    Liu, Shuyling
    Chen, Huiqin
    Meng, Xiaolong
    Kim-Anh Do
    Mills, Gordon B.
    Hortobagyi, Gabriel N.
    Meric-Bernstam, Funda
    Gonzalez-Angulo, Ana M.
    CANCER RESEARCH, 2012, 72
  • [9] Monitoring response to neoadjuvant chemotherapy in triple negative breast cancer using circulating tumor DNA
    Chen, Jennifer H.
    Addanki, Sridevi
    Roy, Dhruvajyoti
    Bassett, Roland
    Kalashnikova, Ekaterina
    Spickard, Erik
    Kuerer, Henry M.
    Meas, Salyna
    Sarli, Vanessa N.
    Korkut, Anil
    White, Jason B.
    Rauch, Gaiane M.
    Tripathy, Debu
    Arun, Banu K.
    Barcenas, Carlos H.
    Yam, Clinton
    Sethi, Himanshu
    Rodriguez, Angel A.
    Liu, Minetta C.
    Moulder, Stacy L.
    Lucci, Anthony
    BMC CANCER, 2024, 24 (01)
  • [10] Monitoring of Triple Negative Breast Cancer After Neoadjuvant Chemotherapy
    Aldrich, Jeffrey
    Canning, Madison
    Bhave, Manali
    CLINICAL BREAST CANCER, 2023, 23 (08) : 832 - 834
12345